517 related articles for article (PubMed ID: 22495066)
1. Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization.
Bai YJ; Huang LZ; Xu XL; Du W; Zhou AY; Yu WZ; Li XX
J Pharmacol Exp Ther; 2012 Jul; 342(1):131-9. PubMed ID: 22495066
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenesis effects of endostatin in retinal neovascularization.
Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
[TBL] [Abstract][Full Text] [Related]
3. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.
Duh EJ; Yang HS; Suzuma I; Miyagi M; Youngman E; Mori K; Katai M; Yan L; Suzuma K; West K; Davarya S; Tong P; Gehlbach P; Pearlman J; Crabb JW; Aiello LP; Campochiaro PA; Zack DJ
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):821-9. PubMed ID: 11867604
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic and Neurogenic Activities of Sleeping Beauty-Mediated PEDF-Transfected RPE Cells In Vitro and In Vivo.
Johnen S; Djalali-Talab Y; Kazanskaya O; Möller T; Harmening N; Kropp M; Izsvák Z; Walter P; Thumann G
Biomed Res Int; 2015; 2015():863845. PubMed ID: 26697494
[TBL] [Abstract][Full Text] [Related]
6. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization.
Ogata N; Wada M; Otsuji T; Jo N; Tombran-Tink J; Matsumura M
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1168-75. PubMed ID: 11923262
[TBL] [Abstract][Full Text] [Related]
7. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization.
Mori K; Duh E; Gehlbach P; Ando A; Takahashi K; Pearlman J; Mori K; Yang HS; Zack DJ; Ettyreddy D; Brough DE; Wei LL; Campochiaro PA
J Cell Physiol; 2001 Aug; 188(2):253-63. PubMed ID: 11424092
[TBL] [Abstract][Full Text] [Related]
8. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
Zhang SX; Wang JJ; Gao G; Parke K; Ma JX
J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919
[TBL] [Abstract][Full Text] [Related]
9. PlGF silencing combined with PEDF overexpression: Modeling RPE secretion as potential therapy for retinal neovascularization.
Araújo RS; Silva GA
Mol Biol Rep; 2020 Jun; 47(6):4413-4425. PubMed ID: 32385771
[TBL] [Abstract][Full Text] [Related]
10. Effect of pigment epithelium derived factor on the expression of glutamine synthetase in early phase of experimental diabetic retinopathy.
Shen X; Xie B; Cheng Y; Jiao Q; Zhong Y
Ocul Immunol Inflamm; 2011 Aug; 19(4):246-54. PubMed ID: 21770802
[TBL] [Abstract][Full Text] [Related]
11. Pigment epithelium-derived factor acts as an opponent of growth-stimulatory factors in retinal glial-endothelial cell interactions.
Yafai Y; Lange J; Wiedemann P; Reichenbach A; Eichler W
Glia; 2007 Apr; 55(6):642-51. PubMed ID: 17309061
[TBL] [Abstract][Full Text] [Related]
12. Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth.
Streck CJ; Zhang Y; Zhou J; Ng C; Nathwani AC; Davidoff AM
J Pediatr Surg; 2005 Jan; 40(1):236-43. PubMed ID: 15868591
[TBL] [Abstract][Full Text] [Related]
13. Pigment Epithelium-Derived Factor-Loaded PEGylated Nanoparticles as a New Antiangiogenic Therapy for Neovascularization.
Zhao F; Fei W; Li Z; Yu H; Xi L
J Diabetes Res; 2022; 2022():1193760. PubMed ID: 35493608
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound-mediated microbubble delivery of pigment epithelium-derived factor gene into retina inhibits choroidal neovascularization.
Zhou XY; Liao Q; Pu YM; Tang YQ; Gong X; Li J; Xu Y; Wang ZG
Chin Med J (Engl); 2009 Nov; 122(22):2711-7. PubMed ID: 19951601
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of neovascularization by the anti-angiogenic factor PEDF.
Apte RS; Barreiro RA; Duh E; Volpert O; Ferguson TA
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4491-7. PubMed ID: 15557459
[TBL] [Abstract][Full Text] [Related]
16. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor.
Zhang SX; Wang JJ; Gao G; Shao C; Mott R; Ma JX
FASEB J; 2006 Feb; 20(2):323-5. PubMed ID: 16368716
[TBL] [Abstract][Full Text] [Related]
17. Beta-adrenergic receptor regulation of pigment epithelial-derived factor expression in rat retina.
Lashbrook BL; Steinle JJ
Auton Neurosci; 2005 Aug; 121(1-2):33-9. PubMed ID: 15961351
[TBL] [Abstract][Full Text] [Related]
18. Ocular wounding prevents pre-retinal neovascularization and upregulates PEDF expression in the inner retina.
Stitt AW; Graham D; Gardiner TA
Mol Vis; 2004 Jun; 10():432-8. PubMed ID: 15235573
[TBL] [Abstract][Full Text] [Related]
19. Pigment epithelium-derived factor inhibits vascular endothelial growth factor-and interleukin-1beta-induced vascular permeability and angiogenesis in retinal endothelial cells.
Sheikpranbabu S; Ravinarayanan H; Elayappan B; Jongsun P; Gurunathan S
Vascul Pharmacol; 2010; 52(1-2):84-94. PubMed ID: 20006737
[TBL] [Abstract][Full Text] [Related]
20. Nornicotine and Nicotine Induced Neovascularization via Increased VEGF/PEDF Ratio.
Zhang Y; Ma A; Wang L; Zhao B
Ophthalmic Res; 2015; 55(1):1-9. PubMed ID: 26536586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]